Search

everythinglearnresearchcommunity

for

Search:↓

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Certain drugs that block specific enzymes can help treat prostate diseases.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.